Form 10-Q Summary
Filing identification: The supplied filing is for Ambac Financial Group, Inc., not OCTAVE SPECIALTY GROUP INC. It reports the quarter and nine months ended September 30, 2020, and was filed November 9, 2020. Financial amounts are in millions except per-share and share data.
Business Context and Reporting Period
Ambac is a financial-services holding company whose principal insurance subsidiaries, Ambac Assurance Corporation and Ambac Assurance UK Limited, are in run-off. The company is focused on reducing insured exposures, managing assets and liabilities, recovering losses, rationalizing capital and debt, and evaluating disciplined new-business opportunities. During the quarter, Ambac acquired Everspan Insurance Company from Ambac Assurance and repositioned it under a new intermediary holding company directly owned by Ambac Financial Group.
Key Financial Metrics
| Metric | Three Months Ended September 30 | Nine Months Ended September 30 |
|---|---|---|
| Net premiums earned | $15 vs. $10 in 2019 | $36 vs. $46 |
| Total revenues | $62 vs. $216 | $68 vs. $406 |
| Losses and loss expenses | $83 vs. $37 | $216 vs. $(84) |
| Net investment income | $37 vs. $45 | $69 vs. $186 |
| Net gains/(losses) on derivatives | $7 vs. $(10) | $(61) vs. $(61) |
| Net income/(loss) attributable to common stockholders | $(108) vs. $66 | $(423) vs. $(106) |
| Diluted loss per share | $(2.33) vs. $1.41 income | $(9.16) vs. $(2.30) |
| Operating expenses | $23 vs. $26 | $67 vs. $80 |
| Interest expense | $50 vs. $67 | $172 vs. $202 |
At September 30, 2020, total assets were $12,812, total liabilities were $11,718, and total stockholders’ equity was $1,095, compared with $13,320, $11,783, and $1,536, respectively, at December 31, 2019. Cash and cash equivalents were $37, restricted cash was $10, and total investments were $3,551.
Nine-month cash flow from operating activities was $(167), investing activities provided $396, and financing activities used $260, resulting in a net cash decrease of $31. Cash, cash equivalents and restricted cash ended at $50, compared with $68 at September 30, 2019.
Long-term debt was $2,737, including $1,648 of Ambac Note debt, $777 of surplus notes and $299 of Tier 2 notes. AFG reported $465 of net assets excluding equity investments in subsidiaries, including $313 of cash and short-term investments.
Material Changes Versus Prior Comparable Period
- Third-quarter net loss was $108, compared with net income of $66 in the prior-year quarter. The change primarily reflected the absence of a $142 SEC/Citigroup settlement receipt recognized in 2019, higher insurance losses, lower investment gains, lower VIE income and lower investment income.
- Nine-month net loss increased to $423 from $106. Losses and loss expenses increased by $300 compared with the 2019 benefit, while net investment income declined by $117 and the 2019 SEC settlement and other restructuring-related items did not recur.
- Losses and loss expenses in the nine-month period were driven primarily by $263 of Domestic Public Finance losses, including Puerto Rico-related reserve strengthening, compared with $197 in 2019. RMBS produced a $91 benefit, while student-loan losses were $24.
- Total insured net par outstanding declined 9% to $34,751 from $38,018 at year-end 2019, reflecting runoff, maturities, calls, refinancings, commutations and currency movements.
- Adversely classified exposures increased 14% to $8,576, while watch-list exposures declined 27% to $4,961. COVID-19-related additions included approximately $975 of previously watch-list exposure moved to adversely classified status.
- Stockholders’ equity declined $441, primarily because of the $423 nine-month net loss and $20 of foreign-currency translation losses. Adjusted book value declined to $891, or $19.44 per share, from $1,313, or $28.83 per share.
Guidance, Outlook, Commentary, Risks and Unusual Items
- Management provided no conventional earnings guidance. It expects continued runoff, further potential de-risking transactions and disciplined evaluation of new businesses.
- COVID-19 increased credit risk, liquidity risk and earnings volatility across public finance, RMBS, student-loan, international and other insured exposures. Management stated that reserves may be understated depending on the duration and severity of the pandemic.
- Puerto Rico remains the principal concentration of uncertainty, with $1,070 of net par exposure. Restructuring proceedings, litigation, political developments, fiscal weakness and uncertain recoveries could materially increase losses.
- For public-finance credits with expected losses, management estimated a possible reserve increase of approximately $1,200 under stress. Such an increase would reduce stockholders’ equity from $1,095 to approximately $(105), and losses could exceed that estimate.
- Recorded RMBS representation-and-warranty subrogation recoveries were $1,731 net of reinsurance. If these recoveries were not realized, management estimated that stockholders’ equity could decline from $1,095 to approximately $(636).
- Ambac Assurance’s statutory policyholder surplus was $933 and qualified statutory capital was $1,477 at September 30, 2020, down from $1,088 and $1,618, respectively, at year-end 2019.
- Ambac UK had a Solvency II eligible-capital deficit of £64 relative to regulatory capital requirements at September 30, 2020, compared with a £30 deficit at year-end 2019. Regulatory discussions remain ongoing.
- OCI declined approval for repayment of Ambac Assurance surplus-note principal and accrued interest scheduled for June 7, 2020. Payments remain subject to OCI approval, and interest continues to accrue.
- Material litigation remains pending in Puerto Rico, RMBS recoveries, student loans and other matters. Outcomes and potential losses generally cannot be estimated reliably and could be material.
- The company adopted CECL on January 1, 2020. The opening retained-earnings impact was not material; the premium-receivable allowance ended at $18.
Important Facts for Investors to Verify
- Confirm the issuer identity: the source text is an Ambac Financial Group 10-Q, despite the request metadata naming OCTAVE SPECIALTY GROUP INC.
- Assess the adequacy and sensitivity of loss reserves, particularly the stated $1,200 public-finance stress increase and COVID-19 assumptions.
- Evaluate the collectability and timing of the $1,731 net RMBS representation-and-warranty recovery asset.
- Review Puerto Rico restructuring plans, litigation outcomes and the potential impact on the $1,070 exposure and future claims.
- Monitor Ambac Assurance liquidity, OCI approval requirements, surplus-note obligations and the company’s ability to service debt.
- Review Ambac UK’s regulatory capital deficit and remediation discussions with regulators.
- Consider the effect of continued insured-portfolio runoff, increasing adversely classified exposure, below-investment-grade concentrations and potential future claims.
- Reconcile GAAP results with non-GAAP adjusted earnings and adjusted book value; the filing reports adjusted nine-month loss of $382 and adjusted book value of $891.